Need Help?

SPECIAL: Dissecting the melanoma ecosystem one cell at the time during immunotherapy

The aim of this study was to identify potential biomarkers of response to immunotherapy (anti-PD1-based) as well as gain understanding of the biological mechanism of therapy resistance (either intrinsic or acquired) in melanoma patients. Single cell RNA sequencing was performed from pre- and on-treatment (2-3 weeks after immunotherapy) metastatic biopsies from stage III and IV melanoma patients.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001009291 unspecified 46
EGAD00001010921 unspecified 6
Publications Citations
CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumours.
Nature 618: 2023 1033-1040
74
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity.
Cancer Cell 41: 2023 1207-1221.e12
19
STmut: a framework for visualizing somatic alterations in spatial transcriptomics data of cancer.
Genome Biol 24: 2023 273
4
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma.
Cell Rep 43: 2024 114406
2